These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3441311)

  • 1. An adenosine analogue, 2-chloroadenosine, protects against long term development of ischaemic cell loss in the rat hippocampus.
    Evans MC; Swan JH; Meldrum BS
    Neurosci Lett; 1987 Dec; 83(3):287-92. PubMed ID: 3441311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term development of selective neuronal loss and the mechanism of protection by 2-amino-7-phosphonoheptanoate in a rat model of incomplete forebrain ischaemia.
    Swan JH; Evans MC; Meldrum BS
    J Cereb Blood Flow Metab; 1988 Feb; 8(1):64-78. PubMed ID: 2828386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mild hypothermia fails to protect late hippocampal neuronal loss following forebrain cerebral ischaemia in rats.
    Tasdemiroglu E
    Acta Neurochir (Wien); 1996; 138(5):570-8; discussion 578-9. PubMed ID: 8800333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 2-chloroadenosine on amygdaloid and hippocampal kindled seizures.
    Bortolotto ZA; Mello LE; Turski L; Cavalheiro EA
    Arch Int Pharmacodyn Ther; 1985 Oct; 277(2):313-20. PubMed ID: 4062442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of 2-chloroadenosine on hippocampal GABA content and turnover.
    Zambotti F; Zonta N; Ferrario P; Zecca L; Mantegazza P
    J Neural Transm; 1986; 65(3-4):167-75. PubMed ID: 3711882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-Chloroadenosine decreases long-term potentiation in the hippocampal CA1 area of the rat.
    de Mendonça A; Ribeiro JA
    Neurosci Lett; 1990 Oct; 118(1):107-11. PubMed ID: 2259460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of delta-opioid receptor stimulation and inhibition on hippocampal survival in a rat model of forebrain ischaemia.
    Iwata M; Inoue S; Kawaguchi M; Nakamura M; Konishi N; Furuya H
    Br J Anaesth; 2007 Oct; 99(4):538-46. PubMed ID: 17704092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketamine fails to protect against ischaemic neuronal necrosis in the rat.
    Jensen ML; Auer RN
    Br J Anaesth; 1988 Aug; 61(2):206-10. PubMed ID: 3415892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of propentofylline (HWA 285) on extracellular purines and excitatory amino acids in CA1 of rat hippocampus during transient ischaemia.
    Andiné P; Rudolphi KA; Fredholm BB; Hagberg H
    Br J Pharmacol; 1990 Aug; 100(4):814-8. PubMed ID: 2207501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotoxicity in organotypic hippocampal slices mediated by adenosine analogues and nitric oxide.
    Barth A; Newell DW; Nguyen LB; Winn HR; Wender R; Meno JR; Janigro D
    Brain Res; 1997 Jul; 762(1-2):79-88. PubMed ID: 9262161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine preconditions against ouabain but not against glutamate on CA1-evoked potentials in rat hippocampal slices.
    Ferguson AL; Stone TW
    Eur J Neurosci; 2008 Nov; 28(10):2084-98. PubMed ID: 19046389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine A2 receptor mediation of pre- and postsynaptic excitatory effects of adenosine in rat hippocampus in vitro.
    Li H; Henry JL
    Eur J Pharmacol; 1998 Apr; 347(2-3):173-82. PubMed ID: 9653878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The adenosine analogue and cerebral protecting agent, AMG-1, has no effect on delayed neuronal death following ischemia.
    Araki H; Karasawa Y; Kawashima K; Hayashi M; Aihara H; Huang JH
    Methods Find Exp Clin Pharmacol; 1989 Dec; 11(12):731-6. PubMed ID: 2626079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine action on interneurons and synaptic transmission onto interneurons in rat hippocampus in vitro.
    Li H; Henry JL
    Eur J Pharmacol; 2000 Nov; 407(3):237-44. PubMed ID: 11068019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central versus peripheral mediation of responses to adenosine receptor agonists: evidence against a central mode of action.
    Brodie MS; Lee K; Fredholm BB; Ståhle L; Dunwiddie TV
    Brain Res; 1987 Jul; 415(2):323-30. PubMed ID: 3038272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LY393615, a novel neuronal Ca(2+) and Na(+) channel blocker with neuroprotective effects in models of in vitro and in vivo cerebral ischemia.
    O'Neill MJ; Hicks CA; Ward MA; Osborne DJ; Wishart G; Mathews KS; McLaughlin DP; Stamford JA; McCarty DR; Patrick KE; Roman C; Fleisch JH; Gilmore J; Boot JR
    Brain Res; 2001 Jan; 888(1):138-149. PubMed ID: 11146060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide mediates interactions between GABAA receptors and adenosine A1 receptors in the rat hippocampus.
    Fragata IR; Ribeiro JA; Sebastião AM
    Eur J Pharmacol; 2006 Aug; 543(1-3):32-9. PubMed ID: 16831416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clenbuterol protects mouse cerebral cortex and rat hippocampus from ischemic damage and attenuates glutamate neurotoxicity in cultured hippocampal neurons by induction of NGF.
    Semkova I; Schilling M; Henrich-Noack P; Rami A; Krieglstein J
    Brain Res; 1996 Apr; 717(1-2):44-54. PubMed ID: 8738252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection of rat hippocampus against ischemic neuronal damage by pretreatment with sublethal ischemia.
    Liu Y; Kato H; Nakata N; Kogure K
    Brain Res; 1992 Jul; 586(1):121-4. PubMed ID: 1380876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroxine attenuates hippocampal neuronal damage caused by ischemia in the rat.
    Rami A; Krieglstein J
    Life Sci; 1992; 50(9):645-50. PubMed ID: 1740972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.